Dr. Hiroshi Yamazaki is a Professor of Laboratory of Drug Metabolism and Pharmacokinetics at Showa Pharmaceutical University, Tokyo, Japan since 2005. After receiving his BS and MS degrees from Gifu Pharmaceutical University and PhD in Pharmaceutical Sciences from Osaka University in Japan, he trained as a post-doctoral fellow at Vanderbilt University School of Medicine, Nashville, TN, the USA in 1994. He was recruited as an Associate Professor of Kanazawa University from Osaka Prefectural Institute of Public Health in 1998 and moved to a post as Associate Professor of Hokkaido University Graduate School of Pharmaceutical Sciences in 2001.
Professor Yamazaki’s research has focused on polymorphic cytochrome P450 and flavin-containing monooxygenase, which are major catalysts involved in drug metabolism in toxicology and pharmacology in humans, and simple physiological-based pharmacokinetic modeling for a variety of chemicals. He has authored over 490 publications with an h-index of 66 (https://www.scopus.com/authid/detail.uri?authorId=57193405959) and is recognized as a ‘Highly Cited Researcher’ in Pharmacology 2001 by Thomson Reuters.